3.71
+0.08(+2.20%)
Currency In USD
Address
400 N Aberdeen St
Chicago, IL 60642
United States of America
Phone
855 226 9991
Sector
Healthcare
Industry
Biotechnology
Employees
13
First IPO Date
January 14, 2022
| Name | Title | Pay | Year Born |
| Dr. Meeshanthini V. Dogan Ph.D. | Co-Founder, Chief Executive Officer & Director | 311,000 | 1989 |
| Mr. Timur Dogan Ph.D. | Chief Technology Officer | 259,167 | 1989 |
| Ms. Elisa Michael Luqman Esq., J.D., M.B.A. | Chief Financial Officer & Principal Accounting Officer | 275,000 | 1964 |
| Ms. Khullani Abdullahi J.D. | Vice President of Revenue & Strategy | 0 | 1984 |
| Dr. Robert A. Philibert M.D., Ph.D. | Co-Founder, Chief Medical Officer & Director | 0 | 1962 |
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.